Advertisement

Human Cell

, Volume 31, Issue 1, pp 72–77 | Cite as

Age-related changes in cyclic phosphatidic acid-induced hyaluronic acid synthesis in human fibroblasts

  • Katsura Sano
  • Mari Gotoh
  • Kyoko Dodo
  • Noriaki Tajima
  • Yoshibumi Shimizu
  • Kimiko Murakami-MurofushiEmail author
Research Article

Abstract

Hyaluronic acid is a major component of the extracellular matrix, which is important for skin hydration. As aging brings skin dehydration, we aimed to clarify the mRNA expression of hyaluronic acid-related proteins in human skin fibroblasts from donors of various ages (range 0.7–69 years). Previously, we reported that cyclic phosphatidic acid (cPA), a unique phospholipid mediator, stimulated the expression of HAS2 and increased hyaluronic acid synthesis in human skin fibroblasts (donor age: 3 days). In this study, we measured the mRNA expression of hyaluronic acid-related proteins: hyaluronan synthase (HAS) 1–3, hyaluronidase-1, -2, and hyaluronic acid-binding protein (versican). In addition, we tested whether cPA could increase hyaluronic acid synthesis in skin fibroblasts derived from donors of various ages. The expression of HAS1, 3, hyaluronidase-1, and -2 did not change with aging. However, the mRNA expression of versican decreased with aging. Although it is thought that the amount of hyaluronic acid in the dermis decreases with aging, the mRNA expression of HAS2 was increased. But the amount of hyaluronic acid secreted by fibroblasts did not increase with aging. This suggests that the activity and/or protein expression of HAS2 decrease with aging. Furthermore, we observed that cPA caused the increase of hyaluronic acid synthesis at any age, and this effect was increased with aging. These results suggest that aging made the fibroblasts more sensitive to cPA treatment. Therefore, cPA represents a suitable candidate for the health maintenance and improvement of the skin by increasing the level of hyaluronic acid in the dermis.

Keywords

Aging Cyclic phosphatidic acid Hyaluronic acid Hyaluronan synthase Human skin fibroblasts Versican 

Abbreviations

BSA

Bovine serum albumin

2ccPA

2-Carba-cPA

cPA

Cyclic phosphatidic acid

CREB

Cyclic adenosine monophosphate response element-binding protein

ERK

Extracellular-signal-regulated kinase

HAS

Hyaluronan synthase

LPA

Lysophosphatidic acid

LPAR

LPA receptor

mRNA

Messenger RNA

PBS

Phosphate-buffered saline

PCR

Polymerase chain reaction

PDL

Population doubling level

ROCK

Rho/Rho-associated kinase

Notes

Acknowledgements

We thank Dr. Kazuhiko Kaji of the Nihon Pharmaceutical University for giving us the fibroblasts. This work was funded by the Grant-in-Aid for Scientific Research (KAKENHI, no. 26860144) from the Ministry of Education, Culture, Sports, Science, and Technology.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest associated with this manuscript.

References

  1. 1.
    Papakonstantinou E, Roth M, Karakiulakis G. A key molecule in skin aging. Dermatoendocrinol. 2012;4:253–8.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Naylor EC, Watson REB, Sherratt MJ. Molecular aspects of skin ageing. Maturitas. 2011;69:249–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Longas MO, Russell CS, He X-Y. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res. 1987;159(1):127–36CrossRefPubMedGoogle Scholar
  4. 4.
    Maeda-Sano K, Gotoh M, Morohoshi T, Someya T, Murofushi H, Murakami-Murofushi K. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts. Biochim Biophys Acta. 2014;1841:1256–63.CrossRefPubMedGoogle Scholar
  5. 5.
    Murakami-Murofushi K, Shioda M, Kaji K, Yoshida S, Murofushi H. Inhibition of eukaryotic DNA polymerase α with a novel lysophosphatidic acid (PHYLPA) isolated from myxoamoebae of Physarum polycephalum. J Biol Chem. 1992;267:21512–7.PubMedGoogle Scholar
  6. 6.
    Kobayashi T, Tanaka-Ishii R, Taguchi R, Ikezawa H, Murakami-Murofushi K. Existence of a bioactive lipid, cyclic phosphatidic acid, bound to human serum albumin. Life Sci. 1999;65:2185–91.CrossRefPubMedGoogle Scholar
  7. 7.
    Murakami-Murofushi K, Uchiyama A, Fujiwara Y, Kobayashi T, Kobayashi S, Mukai M, Murofushi H, Tigyi G. Biological functions of a novel lipid mediator, cyclic phosphatidic acid. Biochem Biophys Acta. 2002;1582:1–7.PubMedGoogle Scholar
  8. 8.
    Fujiwara Y. Cyclic phosphatidic acid—a unique bioactive phospholipid. Biochim Biophys Acta. 2008;1781:519–24.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kobayashi S, Tokunoh R, Shibasaki M, Shinagawa R, Murakami-Murofushi K. Synthesis of 1-O-acylglycerol 2,3-cyclic phosphate: Determination of the absolute structure of PHYLPA, A specific inhibitor of DNA polymerase α. Tetrahedron Lett. 1993;34:4047–50.CrossRefGoogle Scholar
  10. 10.
    Röck K, Meusch M, Fuchs N, Tigges J, Zipper P, Fritsche E, Krutmann J, Homey B, Reifenberger J, Fischer JW. Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes. J Biol Chem. 2012;287:20056–69.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Röck K, Grandoch M, Majora M, Krutmann J, Fischer JW. Collagen fragments inhibit hyaluronan synthesis in skin fibroblasts in response to ultraviolet B (UVB). J Biol Chem. 2011;286:18268–76.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Zhang Z, Zhang J, Miao L, Liu K, Yang S, Pan C, Jiao B. Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. Int J Biol Sci. 2012;8:383–93.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Gotoh M, Hotta H, Murakami-Murofushi K. Effects of cyclic phosphatidic acid on delayed neuronal death following transient ischemia in rat hippocampal CA1. Eur J Pharmacol. 2010;649:206–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Gotoh M, Nagano A, Tsukahara R, Murofushi H, Morohoshi T, Otsuka K, Murakami-Murofushi K. Cyclic phosphatidic acid relieves osteoarthritis symptoms. Mol Pain. 2014;10:52.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, Tammi MI. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J. 2011;278:1419–28.CrossRefPubMedGoogle Scholar
  16. 16.
    Smith MM, Melrose J. Proteoglycans in normal and healing skin. Adv Wound Care (New Rochelle). 2015;4:152–73.CrossRefGoogle Scholar
  17. 17.
    Lee DH, Oh JH, Chung JH. Glycosaminoglycan and proteoglycan in skin aging. J Dermatol Sci. 2016;83:174–81.CrossRefPubMedGoogle Scholar

Copyright information

© Japan Human Cell Society and Springer Japan KK 2017

Authors and Affiliations

  • Katsura Sano
    • 1
    • 2
  • Mari Gotoh
    • 1
    • 3
  • Kyoko Dodo
    • 2
  • Noriaki Tajima
    • 2
  • Yoshibumi Shimizu
    • 1
  • Kimiko Murakami-Murofushi
    • 1
    Email author
  1. 1.Endowed Research Division of Human Welfare SciencesOchanomizu UniversityTokyoJapan
  2. 2.ALBION Co., LtdTokyoJapan
  3. 3.Institute for Human Life InnovationOchanomizu UniversityTokyoJapan

Personalised recommendations